About
Molecular Biology Products, Biosimilars, Generics
Areas of Focus
Categories
BiosimilarsNon-PharmaceuticalGeneric DrugMiddle East
Clinical Trials (22)
View allTotal Trials
22
As Lead Sponsor
20
As Collaborator
2
Total Enrollment
21,461
By Phase
PHASE3: 15PHASE2/PHASE3: 1NA: 1PHASE2: 1PHASE1: 2
By Status
COMPLETED: 19ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1RECRUITING: 1
Clinical Trials Pipeline22 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06406153Lead Sponsor
Efficacy and Safety of YW17 (Laronidase-CinnaGen) Compared to Aldurazyme® in MPS I Patients
PHASE3Completed
12 participants
Started: Sep 10, 2022 · Completed: Nov 18, 2023
NCT05542862Collaborator
Booster Study of SpikoGen COVID-19 Vaccine
PHASE3Completed
81 participants
Started: Sep 7, 2022 · Completed: Sep 16, 2025
NCT05148871Collaborator
Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
PHASE2/PHASE3Active, not recruiting
200 participants
Started: Mar 1, 2022 · Completed: Oct 6, 2024
NCT05231590Lead Sponsor
Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years
PHASE3Completed
581 participants
Started: Feb 23, 2022 · Completed: Sep 30, 2022
NCT05285384Lead Sponsor
Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine
NACompleted
43 participants
Started: Feb 4, 2022 · Completed: Mar 30, 2022
Locations (1)
Headquarters
Tehran, Iran
Map
Loading map...